EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

45 hedge funds and large institutions have $66.2M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.12M
2
+$118K
3
+$61.7K
4
Northern Trust
Northern Trust
Illinois
+$36.8K
5
State Street
State Street
Massachusetts
+$28.9K

Top Sellers

1
-$2.12M
2
-$802K
3
-$367K
4
Morgan Stanley
Morgan Stanley
New York
-$76.1K
5
BCM
Bridgeway Capital Management
Texas
-$65K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$63K
27
$62K
28
$43K
29
$32K
30
$25K
31
$24K
32
$18K
33
$14K
34
$13K
35
$12K
36
$10K
37
$8K
38
$7K
39
$7K
40
$5K
41
$4K
42
$4K
43
$4K
44
$3K
45
$2K
46
$2K
47
$115
48
–
49
–
50
–
1
2